These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27520290)

  • 1. Older patients are still under-represented in clinical trials of Alzheimer's disease.
    Banzi R; Camaioni P; Tettamanti M; Bertele' V; Lucca U
    Alzheimers Res Ther; 2016 Aug; 8():32. PubMed ID: 27520290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors.
    Leinonen A; Koponen M; Hartikainen S
    PLoS One; 2015; 10(5):e0124500. PubMed ID: 25933023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Landscape of Late-Phase Clinical Trials for Alzheimer's Disease: Comparing Regional Variation Between Subjects in Japan and North America.
    Kikuchi M; Adachi N; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2019 Dec; 33(6):511-518. PubMed ID: 31933241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
    Tsoi KK; Hirai HW; Chan JY; Kwok TC
    J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic disparities in clinical trials on Alzheimer's disease: a systematic review.
    Canevelli M; Bruno G; Vico C; Zaccaria V; Lacorte E; Iavicoli I; Vanacore N; Cesari M
    Eur J Neurol; 2018 Apr; 25(4):626-e43. PubMed ID: 29383812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart Disease.
    Bourgeois FT; Orenstein L; Ballakur S; Mandl KD; Ioannidis JPA
    J Am Geriatr Soc; 2017 Nov; 65(11):2354-2361. PubMed ID: 28306144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic gastroesophageal cancer in older patients - is this patient cohort represented in clinical trials?
    Hennessy MA; Hamid M; Keegan NM; Corrigan L; Goggin C; Oo NM; Carrigan M; Mockler D; O'Donovan A; Horgan AM
    BMC Cancer; 2022 Jan; 22(1):3. PubMed ID: 34980003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review.
    Canevelli M; Bruno G; Grande G; Quarata F; Raganato R; Remiddi F; Valletta M; Zaccaria V; Vanacore N; Cesari M
    Neurosci Biobehav Rev; 2019 Jun; 101():122-128. PubMed ID: 30946856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development for Alzheimer's disease: where are we now and where are we headed?
    Sabbagh MN
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):167-85. PubMed ID: 19616185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms.
    Canevelli M; Cesari M; Lucchini F; Valletta M; Sabino M; Lacorte E; Vanacore N; Bruno G
    J Am Geriatr Soc; 2017 Sep; 65(9):2071-2073. PubMed ID: 28682462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing Alzheimer's disease prevention clinical trial populations.
    Grill JD; Monsell SE
    Neurobiol Aging; 2014 Mar; 35(3):466-71. PubMed ID: 24119546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
    Franzen S; Smith JE; van den Berg E; Rivera Mindt M; van Bruchem-Visser RL; Abner EL; Schneider LS; Prins ND; Babulal GM; Papma JM
    Alzheimers Dement; 2022 Apr; 18(4):810-823. PubMed ID: 34590409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer's disease in older adults.
    Beckett MW; Ardern CI; Rotondi MA
    BMC Geriatr; 2015 Feb; 15():9. PubMed ID: 25887627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.
    Prasad V; Goldstein JA
    Eur J Cancer; 2015 Nov; 51(17):2718-23. PubMed ID: 26321010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic inclusion of regions in multiregional clinical trials.
    Song SY; Chee D; Kim E
    Clin Trials; 2019 Feb; 16(1):98-105. PubMed ID: 30444138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of elderly subjects from clinical trials for Parkinson disease.
    Mitchell SL; Sullivan EA; Lipsitz LA
    Arch Neurol; 1997 Nov; 54(11):1393-8. PubMed ID: 9362988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Currents of memory: recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease.
    Viaña JNM; Vickers JC; Cook MJ; Gilbert F
    Neurobiol Aging; 2017 Aug; 56():202-210. PubMed ID: 28385550
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.